(5)Mayo Clinic Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: (5)Mayo Clinic

Poster-Disease-modifying Therapy

October 25, 2021

Safety of Eculizumab in Nmosd and MG Analysis of the Phase 3 Studies Prevent and Regain and Their Extensions

Background: Aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4+ NMOSD) and acetylcholine receptor...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC